Alys Pharmaceuticals Revenue and Competitors
Employee Data
- Alys Pharmaceuticals has 7 Employees.
- Alys Pharmaceuticals grew their employee count by 17% last year.
Alys Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|
What Is Alys Pharmaceuticals?
Launched in February 2024, Alys Pharmaceuticals is an innovation leader in immuno-dermatology, co-founded by Medixci and world-leading dermatology and scientific experts. Originating from the aggregation of six asset-centric Medixci compannies, Alys boasts a robust pipeline of innovative programs and platforms targeting multiple dermatological indications. With a vision to transform the treatment paradigm for several dermatology indications of significant prevalence and major unmet medical need, Alys aspires to redefine the landscape of dermatological treatments. Alys combines the assets and platforms of Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences and Vimela Therapeutics, and has a number of strategic collaborations with leading research institutions.
keywords:N/A
N/A
Total Funding
7
Number of Employees
N/A
Revenue (est)
17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.8M | 7 | -30% | $19.6M |
#2 | $0.8M | 7 | -22% | N/A |
#3 | $0.5M | 7 | N/A | N/A |
#4 | $0.5M | 7 | N/A | N/A |
#5 | $0.1M | 7 | -12% | $7M |